1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

Bayer's Canesten Switched From Rx-To-OTC Status In Poland

 
• By Tom Gallen

Poland's drug regulator, URPL, has switched Bayer's Canesten vaginal yeast infection treatment from prescription-to-OTC status. It is the regulator's fourth switch in 2019 alone.

Canesten
• Source: Shutterstock

Consumers in Poland can now purchase OTC in pharmacy or non-pharmacy outlets Bayer AG’s Canesten vaginal yeast infection treatment after the country’s medicines regulator switched the product from prescription status.

Poland’s Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, URPL, has made available OTC Canesten vaginal capsule...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

German Switch Committee Supports OTC Melatonin And Acyclovir, Rejects Rupatadine

 
• By David Ridley

Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By David Ridley

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

Haleon Study: Self-Care Policies Could Save Finland €60m Per Year

 
• By David Ridley

Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.

More from Health

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By Lauren Nardella

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.

Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By David Ridley

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.

PharmaSGP Increases Sales Forecast Ahead Of Delisting

 
• By Tom Gallen

German consumer health player expects 2025 sales to be €10m higher than previously forecast after a better than predicted showing in the year-to-date.